Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group.

Lancet Infect Dis. 2019 Nov 5. pii: S1473-3099(19)30312-3. doi: 10.1016/S1473-3099(19)30312-3. [Epub ahead of print] Review.

PMID:
31699664
2.

Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study.

Horňák T, Semerád L, Žáčková D, Weinbergerová B, Šustková Z, Procházková J, Bělohlávková P, Stejskal L, Rohoň P, Faber E, Žák P, Mayer J, Ráčil Z.

Leuk Lymphoma. 2019 Oct 3:1-3. doi: 10.1080/10428194.2019.1672054. [Epub ahead of print] No abstract available.

PMID:
31580157
3.

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

Angenendt L, Röllig C, Montesinos P, Martínez-Cuadrón D, Barragan E, García R, Botella C, Martínez P, Ravandi F, Kadia T, Kantarjian HM, Cortes J, Juliusson G, Lazarevic V, Höglund M, Lehmann S, Recher C, Pigneux A, Bertoli S, Dumas PY, Dombret H, Preudhomme C, Micol JB, Terré C, Ráčil Z, Novák J, Žák P, Wei AH, Tiong IS, Wall M, Estey E, Shaw C, Exeler R, Wagenführ L, Stölzel F, Thiede C, Stelljes M, Lenz G, Mikesch JH, Serve H, Ehninger G, Berdel WE, Kramer M, Krug U, Schliemann C.

J Clin Oncol. 2019 Oct 10;37(29):2632-2642. doi: 10.1200/JCO.19.00416. Epub 2019 Aug 20.

PMID:
31430225
4.

EZH2 mutations and impact on clinical outcome - an analysis in 1604 patients with newly diagnosed acute myeloid leukemia.

Stasik S, Middeke JM, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, Crysandt M, Brümmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause S, Herbst R, Hänel M, Frickhofen N, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Rácil Z, Platzbecker U, Berdel WE, Mayer J, Serve H, Müller-Tidow C, Ehninger G, Bornhäuser M, Schetelig J, Thiede C.

Haematologica. 2019 Aug 14. pii: haematol.2019.222323. doi: 10.3324/haematol.2019.222323. [Epub ahead of print]

5.

Application of mini-MLST and whole genome sequencing in low diversity hospital extended-spectrum beta-lactamase producing Klebsiella pneumoniae population.

Bezdicek M, Nykrynova M, Plevova K, Brhelova E, Kocmanova I, Sedlar K, Racil Z, Mayer J, Lengerova M.

PLoS One. 2019 Aug 13;14(8):e0221187. doi: 10.1371/journal.pone.0221187. eCollection 2019.

6.

Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

Salmanton-García J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N, Ráčil Z, Falces-Romero I, Ingram P, Benítez-Peñuela MÁ, Rodríguez JY, Desoubeaux G, Barać A, García-Vidal C, Hoenigl M, Mehta SR, Cheng MP, Klyasova G, Heinz WJ, Iqbal N, Krause R, Ostermann H, Penack O, Schalk E, Sheppard DC, Willinger B, Wisplinghoff H, Vehreschild JJ, Cornely OA, Vehreschild MJGT; FungiScope® ECMM/ISHAM Working Group .

J Antimicrob Chemother. 2019 Nov 1;74(11):3315-3327. doi: 10.1093/jac/dkz344.

PMID:
31393591
7.

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study.

Kayser S, Hills RK, Luskin MR, Brunner AM, Terré C, Westermann J, Menghrajani K, Shaw C, Baer MR, Elliott MA, Perl AE, Ráčil Z, Mayer J, Zak P, Szotkowski T, de Botton S, Grimwade D, Mayer K, Walter RB, Krämer A, Burnett AK, Ho AD, Platzbecker U, Thiede C, Ehninger G, Stone RM, Röllig C, Tallman MS, Estey EH, Müller-Tidow C, Russell NH, Schlenk RF, Levis MJ.

Haematologica. 2019 Apr 19. pii: haematol.2018.208678. doi: 10.3324/haematol.2018.208678. [Epub ahead of print]

8.

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations.

Šestáková Š, Krejčík Z, Folta A, Cerovská E, Šálek C, Merkerová MD, Pecherková P, Ráčil Z, Mayer J, Cetkovský P, Remešová H.

Cancer Biomark. 2019;25(1):43-51. doi: 10.3233/CBM-182176.

PMID:
30988238
9.

Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients.

Folta A, Culen M, Jeziskova I, Herudkova Z, Tom N, Hlubinkova T, Janeckova V, Durinikova A, Vydra J, Semerad L, Dvorakova D, Remesova H, Cerovska E, Cetkovsky P, Jindra P, Szotkowski T, Zak P, Mayer J, Racil Z.

Br J Haematol. 2019 Jul;186(2):300-310. doi: 10.1111/bjh.15916. Epub 2019 Apr 9.

PMID:
30968396
10.

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.

Kuželová K, Brodská B, Schetelig J, Röllig C, Ráčil Z, Walz JS, Helbig G, Fuchs O, Vraná M, Pecherková P, Šálek C, Mayer J.

PLoS One. 2018 Dec 17;13(12):e0204290. doi: 10.1371/journal.pone.0204290. eCollection 2018.

11.

Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR.

Ricna D, Lengerova M, Bezdicek M, Kocmanova I, Drgona L, Weinbergerova B, Mayer J, Racil Z.

Folia Microbiol (Praha). 2019 May;64(3):421-428. doi: 10.1007/s12223-018-00669-w. Epub 2018 Dec 8.

PMID:
30535753
12.

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.

Czech J, Cordua S, Weinbergerova B, Baumeister J, Crepcia A, Han L, Maié T, Costa IG, Denecke B, Maurer A, Schubert C, Feldberg K, Gezer D, Brümmendorf TH, Müller-Newen G, Mayer J, Racil Z, Kubesova B, Knudsen T, Sørensen AL, Holmström M, Kjær L, Skov V, Larsen TS, Hasselbalch HC, Chatain N, Koschmieder S.

Leukemia. 2019 Apr;33(4):995-1010. doi: 10.1038/s41375-018-0295-6. Epub 2018 Nov 23.

PMID:
30470838
13.

The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.

Belohlavkova P, Vrbacky F, Voglova J, Racil Z, Zackova D, Hrochova K, Malakova J, Mayer J, Zak P.

Arch Med Sci. 2018 Oct;14(6):1416-1423. doi: 10.5114/aoms.2018.73538. Epub 2018 Feb 15.

14.

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN).

J Antimicrob Chemother. 2018 Dec 1;73(12):3221-3230. doi: 10.1093/jac/dky286. Review.

PMID:
30085172
15.

Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.

Racil Z, Koritakova E, Sacha T, Klamova H, Belohlavkova P, Faber E, Rea D, Malaskova L, Prochazkova J, Zackova D, Voglova J, Wącław J, Cetkovsky P, Zak P, Mayer J.

Am J Hematol. 2018 Oct;93(10):E342-E345. doi: 10.1002/ajh.25232. Epub 2018 Aug 31. No abstract available.

16.

The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice.

Culen M, Kosarova Z, Jeziskova I, Folta A, Chovancova J, Loja T, Tom N, Bystry V, Janeckova V, Dvorakova D, Mayer J, Racil Z.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1239-1251. doi: 10.1007/s00432-018-2652-2. Epub 2018 May 2.

PMID:
29721667
17.

Chromothripsis in acute myeloid leukemia: biological features and impact on survival.

Fontana MC, Marconi G, Feenstra JDM, Fonzi E, Papayannidis C, Ghelli Luserna di Rorá A, Padella A, Solli V, Franchini E, Ottaviani E, Ferrari A, Baldazzi C, Testoni N, Iacobucci I, Soverini S, Haferlach T, Guadagnuolo V, Semerad L, Doubek M, Steurer M, Racil Z, Paolini S, Manfrini M, Cavo M, Simonetti G, Kralovics R, Martinelli G.

Leukemia. 2018 Jul;32(7):1609-1620. doi: 10.1038/s41375-018-0035-y. Epub 2018 Feb 23.

18.

Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.

Stallmach A, Anttila VJ, Hell M, Gwynn S, Merino-Amador P, Petrosillo N, Ráčil Z, Warren T, Wenisch C, Wilcox M.

Z Gastroenterol. 2018 Feb 9. doi: 10.1055/s-0044-100045. [Epub ahead of print]

PMID:
29426057
19.

Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission.

Vydra J, Šálek C, Schwarz J, Žák P, Novák J, Petečuková V, Pecherková P, Mayer J, Cetkovský P, Ráčil Z.

Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):106-113. doi: 10.1016/j.clml.2017.11.011. Epub 2017 Dec 7.

PMID:
29289481
20.

Chromothripsis in acute myeloid leukemia: Biological features and impact on survival.

Fontana MC, Marconi G, Feenstra JDM, Fonzi E, Papayannidis C, di Rorá AGL, Padella A, Solli V, Franchini E, Ottaviani E, Ferrari A, Baldazzi C, Testoni N, Iacobucci I, Soverini S, Haferlach T, Guadagnuolo V, Semerad L, Doubek M, Steurer M, Racil Z, Paolini S, Manfrini M, Cavo M, Simonetti G, Kralovics R, Martinelli G.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.351. [Epub ahead of print]

21.

Investigation of next-generation sequencing data of Klebsiella pneumoniae using web-based tools.

Brhelova E, Antonova M, Pardy F, Kocmanova I, Mayer J, Racil Z, Lengerova M.

J Med Microbiol. 2017 Nov;66(11):1673-1683. doi: 10.1099/jmm.0.000624. Epub 2017 Oct 25.

PMID:
29068275
22.

FungiScope -Global Emerging Fungal Infection Registry.

Seidel D, Durán Graeff LA, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, Klimko N, Sheppard DC, Herbrecht R, Chowdhary A, Cornely OA, FungiScope Group.

Mycoses. 2017 Aug;60(8):508-516. doi: 10.1111/myc.12631.

PMID:
28730644
23.

[New Drugs in the Treatment of Acute Myeloid Leukemia in the Elderly].

Šustková Z, Čulen M, Semerád L, Ježíšková I, Dvořáková D, Ráčil Z, Mayer J.

Klin Onkol. Summer 2017;30(3):190-196. doi: 10.14735/amko2017190. Review. Czech.

PMID:
28612615
24.

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Kayser S, Krzykalla J, Elliott MA, Norsworthy K, Gonzales P, Hills RK, Baer MR, Ráčil Z, Mayer J, Novak J, Žák P, Szotkowski T, Grimwade D, Russell NH, Walter RB, Estey EH, Westermann J, Görner M, Benner A, Krämer A, Smith BD, Burnett AK, Thiede C, Röllig C, Ho AD, Ehninger G, Schlenk RF, Tallman MS, Levis MJ, Platzbecker U.

Leukemia. 2017 Nov;31(11):2347-2354. doi: 10.1038/leu.2017.92. Epub 2017 Mar 21.

25.

Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.

Durán Graeff L, Seidel D, Vehreschild MJ, Hamprecht A, Kindo A, Racil Z, Demeter J, De Hoog S, Aurbach U, Ziegler M, Wisplinghoff H, Cornely OA; FungiScope Group.

Mycoses. 2017 Apr;60(4):273-279. doi: 10.1111/myc.12595. Epub 2017 Feb 2.

PMID:
28150341
26.

[Molecular Genetic Testing for Acute Myeloid Leukemia].

Janečková V, Semerád L, Ježíšková I, Dvořáková D, Čulen M, Šustková Z, Mayer J, Ráčil Z.

Klin Onkol. Winter 2016;29(6):411-418. Review. Czech.

PMID:
27951719
27.

Serological Approaches.

Weinbergerova B, Kocmanova I, Racil Z, Mayer J.

Methods Mol Biol. 2017;1508:209-221.

PMID:
27837506
28.

Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia.

Jeziskova I, Semerad L, Dvorakova D, Janeckova V, Culen M, Kunetkova T, Mayer J, Racil Z.

Leuk Lymphoma. 2017 Mar;58(3):746-748. doi: 10.1080/10428194.2016.1213832. Epub 2016 Aug 3. No abstract available.

PMID:
27484360
29.

Validation of Minim typing for fast and accurate discrimination of extended-spectrum, beta-lactamase-producing Klebsiella pneumoniae isolates in tertiary care hospital.

Brhelova E, Kocmanova I, Racil Z, Hanslianova M, Antonova M, Mayer J, Lengerova M.

Diagn Microbiol Infect Dis. 2016 Sep;86(1):44-9. doi: 10.1016/j.diagmicrobio.2016.03.010. Epub 2016 Mar 8.

PMID:
27394639
30.

Utility of voriconazole therapeutic drug monitoring: a meta-analysis.

Luong ML, Al-Dabbagh M, Groll AH, Racil Z, Nannya Y, Mitsani D, Husain S.

J Antimicrob Chemother. 2016 Jul;71(7):1786-99. doi: 10.1093/jac/dkw099. Epub 2016 May 10.

PMID:
27165788
31.

Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis.

Bezdicek M, Lengerova M, Ricna D, Weinbergerova B, Kocmanova I, Volfova P, Drgona L, Poczova M, Mayer J, Racil Z.

Med Mycol. 2016 Oct 1;54(7):714-24. doi: 10.1093/mmy/myw032. Epub 2016 May 9.

PMID:
27161789
32.

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.

Culen M, Borsky M, Nemethova V, Razga F, Smejkal J, Jurcek T, Dvorakova D, Zackova D, Weinbergerova B, Semerad L, Sadovnik I, Eisenwort G, Herrmann H, Valent P, Mayer J, Racil Z.

Oncotarget. 2016 May 31;7(22):33016-24. doi: 10.18632/oncotarget.9108.

33.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJGT; VITAL and FungiScope Mucormycosis Investigators.

Lancet Infect Dis. 2016 Jul;16(7):828-837. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9.

PMID:
26969258
34.

Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.

Ricna D, Lengerova M, Palackova M, Hadrabova M, Kocmanova I, Weinbergerova B, Pavlovsky Z, Volfova P, Bouchnerova J, Mayer J, Racil Z.

Mycoses. 2016 Jan;59(1):48-55. doi: 10.1111/myc.12421. Epub 2015 Nov 2.

PMID:
26661324
35.

Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia.

Sustkova Z, Jeziskova I, Dvorakova D, Horky O, Semerad L, Weinbergerova B, Culen M, Mayer J, Racil Z.

Hematol Oncol. 2017 Jun;35(2):244-245. doi: 10.1002/hon.2254. Epub 2015 Aug 27. No abstract available.

PMID:
26310695
36.

Distribution of mutations in DNMT3A gene and the suitability of mutations in R882 codon for MRD monitoring in patients with AML.

Jeziskova I, Musilova M, Culen M, Foltankova V, Dvorakova D, Mayer J, Racil Z.

Int J Hematol. 2015 Nov;102(5):553-7. doi: 10.1007/s12185-015-1856-3. Epub 2015 Aug 20.

PMID:
26290145
37.

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.

Valent P, Sadovnik I, Ráčil Z, Herrmann H, Blatt K, Cerny-Reiterer S, Eisenwort G, Lion T, Holyoake T, Mayer J.

Eur J Clin Invest. 2014 Dec;44(12):1239-45. doi: 10.1111/eci.12368. Review.

PMID:
25371066
38.

Detecting human cytomegalovirus drug resistant mutations and monitoring the emergence of resistant strains using real-time PCR.

Volfova P, Lengerova M, Lochmanova J, Dvorakova D, Ricna D, Palackova M, Weinbergerova B, Mayer J, Racil Z.

J Clin Virol. 2014 Oct;61(2):270-4. doi: 10.1016/j.jcv.2014.07.008. Epub 2014 Jul 22.

PMID:
25130511
39.

BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing.

Musilova M, Razga F, Jurcek T, Jeziskova I, Borsky M, Nemethova V, Zackova D, Culen M, Dvorakova D, Mayer J, Racil Z.

Am J Hematol. 2014 Oct;89(10):1016-7. doi: 10.1002/ajh.23794. Epub 2014 Jul 22. No abstract available.

40.

Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis.

Lengerova M, Racil Z, Hrncirova K, Kocmanova I, Volfova P, Ricna D, Bejdak P, Moulis M, Pavlovsky Z, Weinbergerova B, Toskova M, Mayer J.

J Clin Microbiol. 2014 Aug;52(8):2824-8. doi: 10.1128/JCM.00637-14. Epub 2014 May 21.

41.

Prospective analysis of low-level BCR-ABL1 T315I mutation in CD34 + cells of patients with de novo chronic myeloid leukemia.

Jurcek T, Razga F, Mazancova P, Musilova M, Dvorakova D, Borsky M, Zackova D, Dobesova B, Semerad L, Mayer J, Racil Z.

Leuk Lymphoma. 2014 Aug;55(8):1915-7. doi: 10.3109/10428194.2013.842988. Epub 2014 Feb 6. No abstract available.

PMID:
24304421
42.

Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2.

Klampfl T, Milosevic JD, Puda A, Schönegger A, Bagienski K, Berg T, Harutyunyan AS, Gisslinger B, Rumi E, Malcovati L, Pietra D, Elena C, Della Porta MG, Pieri L, Guglielmelli P, Bock C, Doubek M, Dvorakova D, Suvajdzic N, Tomin D, Tosic N, Racil Z, Steurer M, Pavlovic S, Vannucchi AM, Cazzola M, Gisslinger H, Kralovics R.

PLoS One. 2013 Oct 16;8(10):e77819. doi: 10.1371/journal.pone.0077819. eCollection 2013.

43.

No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.

Racil Z, Razga F, Klamova H, Voglova J, Belohlavkova P, Malaskova L, Potesil D, Muzik J, Zackova D, Polakova KM, Zdrahal Z, Malakova J, Suttnar J, Dyr J, Mayer J.

Hematol Oncol. 2014 Jun;32(2):87-93. doi: 10.1002/hon.2091. Epub 2013 Aug 20. Erratum in: Hematol Oncol. 2014 Sep;32(3):168.

PMID:
23963760
44.

Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications.

Pavlik T, Janousova E, Mayer J, Indrak K, Jarosova M, Klamova H, Zackova D, Voglova J, Faber E, Karas M, Machova Polakova K, Racil Z, Demeckova E, Demitrovicova L, Tothova E, Chudej J, Markuljak I, Cmunt E, Kozak T, Muzik J, Dusek L.

Am J Hematol. 2013 Sep;88(9):790-7. doi: 10.1002/ajh.23508. Epub 2013 Jul 23.

45.

Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.

Krejci M, Doubek M, Dusek J, Brychtova Y, Racil Z, Navratil M, Tomiska M, Horky O, Pospisilova S, Mayer J.

Ann Hematol. 2013 Oct;92(10):1397-403. doi: 10.1007/s00277-013-1790-5. Epub 2013 Jun 1.

PMID:
23728608
46.

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

Pagano L, Cornely OA, Busca A, Caira M, Cesaro S, Gasbarrino C, Girmenia C, Heinz WJ, Herbrecht R, Lass-Flörl C, Nosari A, Potenza L, Racil Z, Rickerts V, Sheppard DC, Simon A, Ullmann AJ, Valentini CG, Vehreschild JJ, Candoni A, Vehreschild MJ.

Haematologica. 2013 Oct;98(10):e127-30. doi: 10.3324/haematol.2012.083063. Epub 2013 May 28. No abstract available.

47.

Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia.

Racil Z, Razga F, Drapalova J, Buresova L, Zackova D, Palackova M, Semerad L, Malaskova L, Haluzik M, Mayer J.

Haematologica. 2013 Oct;98(10):e124-6. doi: 10.3324/haematol.2013.086355. Epub 2013 May 28. No abstract available.

48.

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.

Klamová H, Poláková KM, Mužík J, Ráčil Z, Záčková D, Steinerová K, Karas M, Faber E, Demečková E, Michalovičová-Sninská Z, Voglová J, Demitrovičová L, Mikušková E, Tóthová E, Chudej J, Markuljak I, Cmunt E, Moravcová J, Dvořáková D, Michalová K, Jarošová M, Sťastná MM, Cetkovský P, Dušek L, Koza V, Trněný M, Indrák K.

Cancer Med. 2013 Apr;2(2):216-25. doi: 10.1002/cam4.59. Epub 2013 Feb 21.

49.

Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.

Zackova D, Klamova H, Muzik J, Cmunt E, Racil Z, Machova Polakova K, Dvorakova D, Jurcek T, Razga F, Cetkovsky P, Dusek L, Mayer J.

Leuk Lymphoma. 2013 Oct;54(10):2310-3. doi: 10.3109/10428194.2013.772173. Epub 2013 Feb 28. No abstract available.

PMID:
23373966
50.

Invasive mould disease involving the gastrointestinal tract caused by Neosartorya pseudofischeri in a haematological patient.

Toskova M, Palousova D, Kocmanova I, Pavlovsky Z, Timilsina S, Lengerova M, Mayer J, Racil Z.

Mycoses. 2013 May;56(3):385-8. doi: 10.1111/myc.12038. Epub 2013 Jan 29. No abstract available.

PMID:
23356572

Supplemental Content

Support Center